Patient Satisfaction and Regret After Robot-assisted Radical Prostatectomy: A Decision Regret Analysis.

Objective: To assess treatment satisfaction and decision regret post robot-assisted radical prostatectomy (RARP) and correlate these with clinical, demographic and quality of life indicators. Our study took place at a high-volume United Kingdom center and patients were assessed at a minimum of 18 months postsurgery.

Methods: Patients who underwent RARP between June 2011 and May 2016 were invited to participate through mailed questionnaires.

Molecular markers in prostate cancer. Part II: potential roles in management.

Predicting treatment responses in advanced prostate cancer (PCa) currently centres on prostate-specific antigen (PSA) kinetics and on being able to visualize measurable changes in imaging modalities. New molecular markers have emerged as potential diagnostic and prognostic indicators; these were summarized in Part I of this review in the Asian Journal of Andrology. A number of molecular markers are now being used to enhance PCa imaging and staging.